| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74b7b50944d8e1960440fb1f5440b7fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-472 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01K67-027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 |
| filingDate |
1995-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70204eac846a7f0c7a310cf16dedb3f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf05de8c9d2b6edbe6a1522479b044fb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_885f2bd1b7b3d1a8e31b2a2460462272 |
| publicationDate |
1995-09-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9523512-A1 |
| titleOfInvention |
Terminal complement inhibitor fusion genes and proteins |
| abstract |
Nucleic acid sequences encoding chimeric proteins that comprise a functional portion of a parent terminal complement inhibitor, such as CD59, and a heterologous transmembrane domain are provided. The parent terminal complement inhibitor is modified to inactivate its GPI signal sequence. The heterologous transmembrane domain serves to anchor the chimeric protein to the cell membrane without substantially interfering with the complement inhibitor activity of the terminal complement inhibitor. The nucleic acid sequences and encoded chimeric proteins can be used to protect cells from complement attack. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6498285-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8883413-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7462466-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10174079-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7989589-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9630992-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0202636-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7888323-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8703136-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0894002-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0894002-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169307-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9717987-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10745442-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0202636-A2 |
| priorityDate |
1994-03-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |